Change to method of applicant notification in case of invalid PLPI submission

Medicines regulatory news

2 January 2013

Please note:

From 1 February 2013, we will no longer be sending any email correspondence to advise regarding invalidated PLPI submissions.

We currently send an email followed by a letter with advice regarding invalidated PLPI submissions. This will be changed to a single form of advice; letters will be sent via the applicant’s chosen method of communication (portal or post).

Submission of parallel import applications

Page last modified: 08 March 2013